Literature DB >> 30523547

The pathological spectrum behind migraine aura status: a case series.

Alberto Terrin1, Federico Mainardi2, Ferdinando Maggioni3.   

Abstract

BACKGROUND: The recently released International Classification of Headache Disorders-3rd edition (1) includes migraine aura status (MAS) among the complications of migraine (A1.4.5). It is defined as the recurrence of at least three auras over a period of 3 days, in a patient suffering from migraine fulfilling criteria for 1.2 Migraine with aura (MA) or one of its subtypes. CASE SERIES: We describe three cases of MAS secondary to an organic brain lesion: a migrainous infarction, an acute ischemic stroke secondary to a vertebral artery dissection, and an inflammatory demyelinating disease of the central nervous system.
CONCLUSIONS: In front of a patient with a MAS, an organic lesion of the brain must be suspected, until a complete negative vascular and neuroradiological diagnostic workup has been performed. A spectrum of underlying pathologies (vascular or demyelinating diseases, epileptic or degenerative conditions) may cause a MAS-like clinical onset. The variability of aura symptoms may result in a real diagnostic challenge.

Entities:  

Keywords:  Inflammatory diseases; Ischemic stroke; Migrainous infarction; Recurrent auras; Spectrum

Mesh:

Year:  2018        PMID: 30523547     DOI: 10.1007/s10072-018-3671-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  3 in total

1.  Cortical laminar necrosis in a patient with an embolic stroke of undetermined source: the metabolism patterns on PET/CT.

Authors:  Xuying Xiang; Fei Cao
Journal:  Neurol Sci       Date:  2021-07-29       Impact factor: 3.307

2.  Solving the conundrum. A migrainous infarction or an infarct-induced migrainous attack?

Authors:  B Hebant; L Simmonet; J Le Moal; E Guegan-Massardier
Journal:  J Postgrad Med       Date:  2019 Jul-Sep       Impact factor: 1.476

Review 3.  Symptoms related to the visual system in migraine.

Authors:  Robin M van Dongen; Joost Haan
Journal:  F1000Res       Date:  2019-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.